Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study.
Verzoni E, De Giorgi U, Derosa L, Caffo O, Boccardo F, Facchini G, Porcu L, De Vincenzo F, Zaniboni A, Chiuri VE, Fratino L, Santini D, Adamo V, De Vivo R, Dinota A, Messina C, Ricotta R, Caserta C, Scavelli C, Susi M, Tartarone A, Surace G, Mosca A, Bruno M, Barni S, Grassi P, Procopio G. Verzoni E, et al. Among authors: boccardo f. Oncotarget. 2016 Jun 28;7(26):40085-40094. doi: 10.18632/oncotarget.9485. Oncotarget. 2016. PMID: 27223078 Free PMC article.
Prognostic value of nuclear matrix protein expression in localized prostate cancer.
Ricci F, Rubagotti A, Zinoli L, Mangerini R, Nuzzo PV, Carmignani G, Simonato A, Barboro P, Balbi C, Boccardo F. Ricci F, et al. Among authors: boccardo f. J Cancer Res Clin Oncol. 2012 Aug;138(8):1379-84. doi: 10.1007/s00432-012-1216-0. Epub 2012 Apr 10. J Cancer Res Clin Oncol. 2012. PMID: 22488172
Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort.
Iacovelli R, Cartenì G, Sternberg CN, Milella M, Santoni M, Di Lorenzo G, Ortega C, Sabbatini R, Ricotta R, Messina C, Lorusso V, Atzori F, De Vincenzo F, Sacco C, Boccardo F, Valduga F, Massari F, Baldazzi V, Cinieri S, Mosca A, Ruggeri EM, Berruti A, Cerbone L, Procopio G. Iacovelli R, et al. Among authors: boccardo f. Eur J Cancer. 2013 Jun;49(9):2134-42. doi: 10.1016/j.ejca.2013.02.032. Epub 2013 Mar 18. Eur J Cancer. 2013. PMID: 23518211
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.
Bracarda S, Gernone A, Gasparro D, Marchetti P, Ronzoni M, Bortolus R, Fratino L, Basso U, Mazzanti R, Messina C, Tucci M, Boccardo F, Cartenì G, Pinto C, Fornarini G, Mattioli R, Procopio G, Chiuri V, Scotto T, Dondi D, Di Lorenzo G. Bracarda S, et al. Among authors: boccardo f. Future Oncol. 2014 May;10(6):975-83. doi: 10.2217/fon.13.256. Epub 2013 Dec 3. Future Oncol. 2014. PMID: 24295376 Free article. Clinical Trial.
Safety of antiandrogen therapy for treating prostate cancer.
Ricci F, Buzzatti G, Rubagotti A, Boccardo F. Ricci F, et al. Among authors: boccardo f. Expert Opin Drug Saf. 2014 Nov;13(11):1483-99. doi: 10.1517/14740338.2014.966686. Epub 2014 Oct 1. Expert Opin Drug Saf. 2014. PMID: 25270521 Review.
Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.
Iacovelli R, Farcomeni A, Sternberg CN, Cartenì G, Milella M, Santoni M, Cerbone L, Di Lorenzo G, Verzoni E, Ortega C, Sabbatini R, Ricotta R, Messina C, Lorusso V, Atzori F, De Vincenzo F, Sacco C, Boccardo F, Valduga F, Massari F, Baldazzi V, Cinieri S, Mosca A, Maria Ruggeri E, Berruti A, Procopio G. Iacovelli R, et al. Among authors: boccardo f. J Urol. 2015 Jun;193(6):1905-10. doi: 10.1016/j.juro.2014.11.092. Epub 2014 Nov 26. J Urol. 2015. PMID: 25433306
Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from (223)Ra-dichloride to new horizons for therapeutic response assessment.
Bombardieri E, Evangelista L, Ceresoli GL, Boccardo F. Bombardieri E, et al. Among authors: boccardo f. Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):5-7. doi: 10.1007/s00259-015-3189-0. Epub 2015 Sep 18. Eur J Nucl Med Mol Imaging. 2016. PMID: 26381776 No abstract available.
Treatment of elderly patients with metastatic renal cell carcinoma.
Zanardi E, Grassi P, Cavo A, Verzoni E, Maggi C, De Braud F, Boccardo F, Procopio G. Zanardi E, et al. Among authors: boccardo f. Expert Rev Anticancer Ther. 2016;16(3):323-34. doi: 10.1586/14737140.2016.1131613. Epub 2016 Jan 20. Expert Rev Anticancer Ther. 2016. PMID: 26654225 Review.
397 results